Skip over global navigation links
U.S. Department of Health and Human Services
  • FDA approval of TPOXX® as a treatment for smallpox

    “The Food and Drug Administration’s (FDA) approval of TPOXX® (tecovirimat) as a treatment for smallpox marks a milestone for biosecurity and a triumph against one of the most deadly diseases in history. TPOXX®, produced by SIGA Technologies, is the first – and only—FDA-approved smallpox antiviral treatment.”

    button 

    pill capsules 

PHE Newsroom

Submit an Inquiry

 

Watch, Listen, Subscribe

 
Facebook Exit Icon Twitter Exit Icon YouTube Exit Icon
Email via GovDelivery Exit Icon LinkedIn Exit Icon

  • This page last reviewed: July 13, 2018